171 related articles for article (PubMed ID: 31570427)
21. Effect of the vascular endothelial growth factor receptor-2 antibody DC101 plus gemcitabine on growth, metastasis and angiogenesis of human pancreatic cancer growing orthotopically in nude mice.
Bruns CJ; Shrader M; Harbison MT; Portera C; Solorzano CC; Jauch KW; Hicklin DJ; Radinsky R; Ellis LM
Int J Cancer; 2002 Nov; 102(2):101-8. PubMed ID: 12385004
[TBL] [Abstract][Full Text] [Related]
22. Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.
Arumugam T; Ramachandran V; Logsdon CD
J Natl Cancer Inst; 2006 Dec; 98(24):1806-18. PubMed ID: 17179482
[TBL] [Abstract][Full Text] [Related]
23. The Adnectin CT-322 is a novel VEGF receptor 2 inhibitor that decreases tumor burden in an orthotopic mouse model of pancreatic cancer.
Dineen SP; Sullivan LA; Beck AW; Miller AF; Carbon JG; Mamluk R; Wong H; Brekken RA
BMC Cancer; 2008 Nov; 8():352. PubMed ID: 19038046
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of SRC tyrosine kinase as treatment for human pancreatic cancer growing orthotopically in nude mice.
Yezhelyev MV; Koehl G; Guba M; Brabletz T; Jauch KW; Ryan A; Barge A; Green T; Fennell M; Bruns CJ
Clin Cancer Res; 2004 Dec; 10(23):8028-36. PubMed ID: 15585638
[TBL] [Abstract][Full Text] [Related]
25. EGFR-targeted gelatin nanoparticles for systemic administration of gemcitabine in an orthotopic pancreatic cancer model.
Singh A; Xu J; Mattheolabakis G; Amiji M
Nanomedicine; 2016 Apr; 12(3):589-600. PubMed ID: 26656632
[TBL] [Abstract][Full Text] [Related]
26. Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer.
Suzuki K; Aiura K; Matsuda S; Itano O; Takeuchi O; Umezawa K; Kitagawa Y
Clin Exp Metastasis; 2013 Apr; 30(4):381-92. PubMed ID: 23111540
[TBL] [Abstract][Full Text] [Related]
27. Ginkgolide B enhances gemcitabine sensitivity in pancreatic cancer cell lines via inhibiting PAFR/NF-кB pathway.
Lou C; Lu H; Ma Z; Liu C; Zhang Y
Biomed Pharmacother; 2019 Jan; 109():563-572. PubMed ID: 30399592
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of PDGFR phosphorylation and Src and Akt activity by GN963 leads to therapy of human pancreatic cancer growing orthotopically in nude mice.
Baker CH; Trevino JG; Summy JM; Zhang F; Caron A; Nesbit M; Gallick GE; Fidler IJ
Int J Oncol; 2006 Jul; 29(1):125-38. PubMed ID: 16773192
[TBL] [Abstract][Full Text] [Related]
29. Antimetastatic effects of liposomal gemcitabine and empty liposomes in an orthotopic mouse model of pancreatic cancer.
Graeser R; Bornmann C; Esser N; Ziroli V; Jantscheff P; Unger C; Hopt UT; Schaechtele C; von Dobschuetz E; Massing U
Pancreas; 2009 Apr; 38(3):330-7. PubMed ID: 19142174
[TBL] [Abstract][Full Text] [Related]
30. A new liposomal formulation of Gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging.
Bornmann C; Graeser R; Esser N; Ziroli V; Jantscheff P; Keck T; Unger C; Hopt UT; Adam U; Schaechtele C; Massing U; von Dobschuetz E
Cancer Chemother Pharmacol; 2008 Mar; 61(3):395-405. PubMed ID: 17554540
[TBL] [Abstract][Full Text] [Related]
31. RC-3095, a gastrin-releasing peptide receptor antagonist, synergizes with gemcitabine to inhibit the growth of human pancreatic cancer CFPAC-1 in vitro and in vivo.
Hong SK; Yang SY; Yin SH; Yang KX
Pancreas; 2014 Jan; 43(1):15-21. PubMed ID: 24326363
[TBL] [Abstract][Full Text] [Related]
32. Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer.
Blaauboer A; Booy S; van Koetsveld PM; Karels B; Dogan F; van Zwienen S; van Eijck CHJ; Hofland LJ
BMC Cancer; 2020 Sep; 20(1):913. PubMed ID: 32967656
[TBL] [Abstract][Full Text] [Related]
33. Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival.
Ogura Y; Mizumoto K; Nagai E; Murakami M; Inadome N; Saimura M; Matsumoto K; Nakamura T; Maemondo M; Nukiwa T; Tanaka M
Cancer Gene Ther; 2006 May; 13(5):520-9. PubMed ID: 16341142
[TBL] [Abstract][Full Text] [Related]
34. Antitumor effect of gemcitabine on orthotopically inoculated human gallbladder cancer cells in nude mice.
Mita Y; Ajiki T; Kamigaki T; Okazaki T; Hori H; Horiuchi H; Hirata K; Fujita T; Fujimori T; Kuroda Y
Ann Surg Oncol; 2007 Apr; 14(4):1374-80. PubMed ID: 17235714
[TBL] [Abstract][Full Text] [Related]
35. Efficacy Evaluation of Combination Treatment Using Gemcitabine and Radioimmunotherapy with
Sugyo A; Tsuji AB; Sudo H; Koizumi M; Ukai Y; Kurosawa G; Kurosawa Y; Saga T; Higashi T
Int J Mol Sci; 2018 Sep; 19(10):. PubMed ID: 30274301
[TBL] [Abstract][Full Text] [Related]
36. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.
Kozono S; Ohuchida K; Eguchi D; Ikenaga N; Fujiwara K; Cui L; Mizumoto K; Tanaka M
Cancer Res; 2013 Apr; 73(7):2345-56. PubMed ID: 23348422
[TBL] [Abstract][Full Text] [Related]
37. DKK3 blocked translocation of β-catenin/EMT induced by hypoxia and improved gemcitabine therapeutic effect in pancreatic cancer Bxpc-3 cell.
Guo Q; Qin W
J Cell Mol Med; 2015 Dec; 19(12):2832-41. PubMed ID: 26395974
[TBL] [Abstract][Full Text] [Related]
38. [Experimental study of the function and mechanism combining dihydroartemisinin and gemcitabine in treating pancreatic cancer].
Wang SJ; Sun B; Pan SH; Chen H; Kong R; Li J; Xue DB; Bai XW; Jiang HC
Zhonghua Wai Ke Za Zhi; 2010 Apr; 48(7):530-4. PubMed ID: 20646665
[TBL] [Abstract][Full Text] [Related]
39. The utility of hyperthermic intra-abdominal chemotherapy with gemcitabine for the inhibition of tumor progression in an experimental model of pancreatic peritoneal carcinomatosis, in relation to their behavior with pancreatic cancer stem cells CD133+ CXCR4.
García-Santos EP; Padilla-Valverde D; Villarejo-Campos P; Murillo-Lázaro C; Fernández-Grande E; Palomino-Muñoz T; Rodríguez-Martínez M; Amo-Salas M; Nuñez-Guerrero P; Sánchez-García S; Puerto-Puerto A; Martín-Fernández J
Pancreatology; 2016; 16(4):632-9. PubMed ID: 27289344
[TBL] [Abstract][Full Text] [Related]
40. Pressure-enabled delivery of gemcitabine in an orthotopic pancreatic cancer mouse model.
Shankara Narayanan JS; Vicente DA; Ray P; Chai LF; Erdem S; Carr MJ; Capacio BA; Cox BF; Jaroch DB; Katz SC; White RR
Surgery; 2020 Sep; 168(3):448-456. PubMed ID: 32620306
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
